Know Cancer

or
forgot password

Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in PCOS Patients.


Phase 4
18 Years
40 Years
Open (Enrolling)
Female
Depression, PCOS

Thank you

Trial Information

Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in PCOS Patients.


Inclusion Criteria:



- Women diagnosed of PCOS according to Rotterdam 2003 criteria

Exclusion Criteria:

- BMI >30

- Pharmacological treatment in the last 3 moths

- Use of contraceptive pill

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Outcome Measure:

Hamilton Rating Scale for depression

Principal Investigator

Vittorio Unfer, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

AGUNCO Obstetrics and Gynecology Centre

Authority:

Italy: National Institute of Health

Study ID:

agunco7/2010

NCT ID:

NCT01246310

Start Date:

November 2010

Completion Date:

Related Keywords:

  • Depression
  • PCOS
  • Mental Disorders
  • Depression
  • Depressive Disorder
  • Polycystic Ovary Syndrome

Name

Location